187 related articles for article (PubMed ID: 37629159)
1. A Novel Multi-Component Formulation Reduces Inflammation In Vitro and Clinically Lessens the Symptoms of Chronic Eczematous Skin.
Kim J; Jung E; Yang W; Kim CK; Durnaoglu S; Oh IR; Kim CW; Sinskey AJ; Mihm MC; Lee JH
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629159
[TBL] [Abstract][Full Text] [Related]
2. Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory effects and alleviate clinical symptoms of atopic eczema.
Oláh A; Szabó-Papp J; Soeberdt M; Knie U; Dähnhardt-Pfeiffer S; Abels C; Bíró T
J Dermatol Sci; 2017 Oct; 88(1):67-77. PubMed ID: 28610718
[TBL] [Abstract][Full Text] [Related]
3. In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models.
Engelhart K; El Hindi T; Biesalski HK; Pfitzner I
Arch Dermatol Res; 2005 Jul; 297(1):1-9. PubMed ID: 15952007
[TBL] [Abstract][Full Text] [Related]
4. Development of a new eczema-like reconstructed skin equivalent for testing child atopic dermatitis-relieving cosmetics.
Gu H; Zhu Y; Jia T; Li X; Lu Y; Kaku K
J Cosmet Dermatol; 2020 Mar; 19(3):752-757. PubMed ID: 31313888
[TBL] [Abstract][Full Text] [Related]
5. Pseudoephedrine alleviates atopic dermatitis-like inflammatory responses in vivo and in vitro.
Chen X; Lin J; Liang Q; Chen X; Wu Z
Life Sci; 2020 Oct; 258():118139. PubMed ID: 32721463
[TBL] [Abstract][Full Text] [Related]
6. Morus alba fruits attenuates atopic dermatitis symptoms and pathology in vivo and in vitro via the regulation of barrier function, immune response and pruritus.
Kim HM; Kang YM; Jin BR; Lee H; Lee DS; Lee M; An HJ
Phytomedicine; 2023 Jan; 109():154579. PubMed ID: 36610150
[TBL] [Abstract][Full Text] [Related]
7. Recent studies of cutaneous nociception in atopic and non-atopic subjects.
Heyer GR; Hornstein OP
J Dermatol; 1999 Feb; 26(2):77-86. PubMed ID: 10091477
[TBL] [Abstract][Full Text] [Related]
8. Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study.
Eichenfield LF; Gower RG; Xu J; Alam MS; Su JC; Myers DE; Sanders P; Vlahos B; Zang C; Lan J; Werth J
Am J Clin Dermatol; 2023 Jul; 24(4):623-635. PubMed ID: 37184828
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-124 alleviates chronic skin inflammation in atopic eczema via suppressing innate immune responses in keratinocytes.
Yang Z; Zeng B; Wang C; Wang H; Huang P; Pan Y
Cell Immunol; 2017 Sep; 319():53-60. PubMed ID: 28847568
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of ixerisoside A against UVB-induced pro-inflammatory cytokine production in human keratinocytes.
Kim SB; Kim JE; Kang OH; Mun SH; Seo YS; Kang DH; Yang DW; Ryu SY; Lee YM; Kwon DY
Int J Mol Med; 2015 May; 35(5):1411-8. PubMed ID: 25738262
[TBL] [Abstract][Full Text] [Related]
11. Saikosaponin A and Saikosaponin C Reduce TNF-α-Induced TSLP Expression through Inhibition of MAPK-Mediated EGR1 Expression in HaCaT Keratinocytes.
Ahn SS; Lee YH; Yeo H; Jung E; Lim Y; Shin SY
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563251
[TBL] [Abstract][Full Text] [Related]
12. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.
Matterne U; Böhmer MM; Weisshaar E; Jupiter A; Carter B; Apfelbacher CJ
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012167. PubMed ID: 30666626
[TBL] [Abstract][Full Text] [Related]
13. The Anti-Inflammatory and Skin Barrier Function Recovery Effects of
Son Y; Yang W; Park S; Yang J; Kim S; Lyu JH; Kim H
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512164
[No Abstract] [Full Text] [Related]
14. Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment with 60 mg nemolizumab subcutaneously every 4 weeks: subgroup analysis from a phase 3, randomized, controlled trial.
Kabashima K; Matsumura T; Hayakawa Y; Kawashima M;
J Dermatolog Treat; 2023 Dec; 34(1):2177096. PubMed ID: 36779675
[TBL] [Abstract][Full Text] [Related]
15. TNFα and IL-17A are differentially expressed in psoriasis-like vs eczema-like drug reactions to TNFα antagonists.
Deubelbeiss C; Kolios AGA; Anzengruber F; French LE; Yawalkar N; Kempf W; Kerl K; Meier B; Navarini AA
J Cutan Pathol; 2018 Jan; 45(1):23-28. PubMed ID: 29023827
[TBL] [Abstract][Full Text] [Related]
16. Icariin inhibits TNF-α/IFN-γ induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes.
Kong L; Liu J; Wang J; Luo Q; Zhang H; Liu B; Xu F; Pang Q; Liu Y; Dong J
Int Immunopharmacol; 2015 Dec; 29(2):401-407. PubMed ID: 26507164
[TBL] [Abstract][Full Text] [Related]
17. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
18. Terminalia chebula Retz. extract ameliorates the symptoms of atopic dermatitis by regulating anti-inflammatory factors in vivo and suppressing STAT1/3 and NF-ĸB signaling in vitro.
Kim HJ; Song HK; Park SH; Jang S; Park KS; Song KH; Lee SK; Kim T
Phytomedicine; 2022 Sep; 104():154318. PubMed ID: 35830757
[TBL] [Abstract][Full Text] [Related]
19. Caffeic acid reduces cutaneous tumor necrosis factor alpha (TNF-α), IL-6 and IL-1β levels and ameliorates skin edema in acute and chronic model of cutaneous inflammation in mice.
Zhang M; Zhou J; Wang L; Li B; Guo J; Guan X; Han Q; Zhang H
Biol Pharm Bull; 2014; 37(3):347-54. PubMed ID: 24583856
[TBL] [Abstract][Full Text] [Related]
20. Dehydroxymethylepoxyquinomicin suppresses atopic dermatitis-like lesions in a stratum corneum-removed murine model through NF-κB inhibition.
Jiang X; He H; Xie Z; Wen H; Li X; Li X; Ma J; Umezawa K; Zhang Y
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):32-39. PubMed ID: 30724631
[No Abstract] [Full Text] [Related]
[Next] [New Search]
